About Biospring Partners
Biospring Partners is a venture capital firm founded in 2020. It is primarily based out of New York City, United States. As of Jan 2025, Biospring Partners has invested in 6 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series B round of Labviva Overall, Biospring Partners portfolio has seen 2 acquisitions, namely Abzena and Serán BioScience. A lot of funds co-invest with Biospring Partners, with names like Kaiser Permanente sharing a substantial percentage of its portfolio. Biospring Partners has team of 21 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Post IPO & 2 more
Portfolio Acquisitions
Biospring Partners' List of Top Investments
Biospring Partners has a portfolio of 6 companies. Their most notable investments are in PathAI and Labviva.Their portfolio spans across United States and United Kingdom. They have invested in Enterprise Applications, HealthTech, Life Sciences and 3 other sectors, across stages such as Series A, Post IPO and 2 more. Here is the list of top investments by Biospring Partners:
1. PathAI
Provider of digital pathology image management system for clinical labs. It offers an AISight is a cloud-native intelligent enterprise workflow solution used by the laboratories and research centers to power their digital pathology workflows and AI applications. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases.
Key facts about PathAI
- Founded Year: 2016
- Location: Boston (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $255M
- Employee Count: 279 as on Sep 30, 2026
- Investors: Deep Learning, General Atlantic and 22 Others
- Latest Funding Round: Series C, May 18, 2021, $*****
- Highlight: Editors' Pick
2. Abzena
Provider of antibody discovery, cell line development, and bio analytics services. The company mainly provides proprietary technologies, mammalian and bio conjugates manufacturing, peptide synthesis, analytical development, cell line development, and bio assays services.
Key facts about Abzena
- Founded Year: 2001
- Location: Cambridge (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2025
- Stage: Acquired
- Total Funding till date: $67.1M
- Employee Count: 446 as on Sep 30, 2026
- Investors: YFM Equity Partners, Welsh, Carson, Anderson & Stowe and 11 Others
- Latest Funding Round: Post IPO, Mar 31, 2022, $*****
- Highlight: Acquired
3. ixLayer
ixLayer provides a cloud-based solution for precision and population health testing. The features of the solution are the integration of the clinical lab, customer relation management, genomic cloud for hosting, bioinformatics tools, clinical health test, and others.
Key facts about ixLayer
- Founded Year: 2017
- Location: San Francisco (United States)
- Stage: Series A
- Total Funding till date: $75M
- Employee Count: 39 as on Aug 31, 2026
- Investors: Salesforce Ventures, Salesforce and 14 Others
- Latest Funding Round: Series A, Aug 24, 2021, $*****
- Highlight: Editors' Pick
Key facts about Serán BioScience
- Founded Year: 2016
- Location: Bend (United States)
- Stage: Acquired
- Employee Count: 187 as on Sep 30, 2026
- Investors: Bain Capital Life Sciences and Biospring Partners
- Latest Funding Round: Seed, Sep 17, 2024, $*****
- Highlight: Acquired
5. Labviva
Digital marketplace for life science products. The company has developed an AI-powered digital marketplace that connects researchers with suppliers of reagents, chemicals, and instrumentation in the life sciences industry. It integrates with procurement systems
Key facts about Labviva
- Founded Year: 2017
- Location: Cambridge (United States)
- Stage: Series B
- Total Funding till date: $55.8M
- Employee Count: 66 as on Aug 31, 2026
- Investors: B Capital, Senator Investment Group and 7 Others
- Latest Funding Round: Series B, Jan 13, 2025, $*****
- Highlight: Editors' Pick
Biospring Partners' Year-on-Year Investment Trends
Biospring Partners has invested in 6 companies over the last 6 years, with an average of 0 new investment annually in the last 5 years. In 2025, it made 1 investment. Its most recent first time investment was in Serán BioScience and most recent follow-on round was in Labviva.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
Biospring Partners' Investments by Stage
Biospring Partners has made 2 investments in Series A stage with an average round size of $20M, 1 investment in Post IPO stage with an average round size of $10M, 1 investment in Seed stage and 1 investment in Series C stage with an average round size of $165M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Post IPO | 1 |
Seed | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Biospring Partners' Investments by Sector
Biospring Partners has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Healthcare, Life Sciences and Vertical SaaS. Notably, it has invested in 4 Enterprise (B2B) companies, 3 Tech companies, 2 Saas companies and at least 2 companies focusing on Software.Sector | No. of Investments |
|---|---|
HealthTech | 3 |
Enterprise Applications | 2 |
Healthcare | 2 |
Life Sciences | 2 |
Vertical SaaS | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
Biospring Partners' Investments by Geography
Biospring Partners has made most investments in United States (4), followed by United Kingdom where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 4 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Biospring Partners' recent investments
Biospring Partners has not made any investment in 2026 so far.Here are the most recent investments by Biospring Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 13, 2025 | United States | Series B | 9208 | [+2] | |
Sep 17, 2024 | United States | Seed | 2185 | ||
Mar 27, 2023 | United States | Series A | 3661 | ||
Mar 31, 2022 | United Kingdom | Post IPO | 3974 | ||
Aug 24, 2021 | United States | Series A | 3982 | [+1] |
Acquired companies in Biospring Partners' Portfolio
2 companies from Biospring Partners' portfolio have been acquired. The most recent acquisition was Serán BioScience in Jan 2021 by Vivo Capital for $*****.Here are Biospring Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 08, 2021 | Sep 17, 2024 | Seed | 1697 | |
Aug 16, 2018 | Jul 28, 2020 | Post IPO | 5667 |
Team profile of Biospring Partners
Biospring Partners has a team of 21 members including 3 Partners and 5 Principals located in United States. Biospring Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Biospring Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Washington | - | - | |
Partner | New York | - | - | |
Partner | Wilmington | - | - | |
Principal | Greenwich | - | - | |
Principal | Pittsburgh | - | - | |
Principal | California | - | - | |
Principal | - | - | - | |
Principal | New York | - | - |
Co-investors of Biospring Partners
Over the past 6 years, 37 investors have co-invested in Biospring Partners's portfolio companies. This includes funds and angels.
- Invested before Biospring Partners: General Catalyst, Pillar VC and 25 others have invested in rounds before Biospring Partners. There are 2 companies where General Catalyst has invested before Biospring Partners and 1 company where Pillar VC has invested before Biospring Partners.
- Top Co-investors of Biospring Partners: 8 investors entered a company along with Biospring Partners. These include investors like Kaiser Permanente (1 company).
- Invested after Biospring Partners: Welsh, Carson, Anderson & Stowe (1 company) and 53 Stations (1 company) are the investors which have invested in Biospring Partners's portfolio after their investments.
Recent News related to Biospring Partners
•
Labviva Secures $25 Million to Enhance AI-Driven Life Sciences Procurement PlatformN24•Jan 13, 2025•Labviva, 53 Stations, Biospring Partners, Capital Group and 3 others
•
Labviva Secures $20M in Series A Financing to Transform the Life Sciences Procurement Industry Using AIBusiness Wire•Mar 27, 2023•Labviva, Biospring Partners, B Capital, Glasswing Ventures and 2 others
•
Biospring Partners Closes $245 Million First Fund As Private Markets Tense UpSTAT•Jun 08, 2022•Biospring Partners
•
Abzena secures $65m to expand production capacityBioPharma-Reporter•Mar 31, 2022•Abzena, Welsh, Carson, Anderson & Stowe, Biospring Partners
•
Ncardia raises more than $ 60 million to improve and expand its Induced Pluripotent Stem Cell (iPSC) offeringsBusiness Wire•Nov 17, 2021•Ncardia, Kiniciti, Welsh, Carson, Anderson & Stowe, Biospring Partners
•
PathAI Announces Completion of $165 Million Financing for Advancing Medicine with AI-powered PathologyPR Newswire•May 18, 2021•PathAI, General Atlantic, Tiger Global Management, 8VC and 12 others
•
Abzena Receives $10M Investment from Biospring PartnersContract Pharma•Jul 28, 2020•Abzena, Biospring Partners
